Sabra Health Care REIT is poised for FFO growth and SHOP-driven upside, offering a 6.6% yield with improving payout ratios.
Bristol Myers Squibb offers value for long-term income investors with a 5.55% yield and growth potential. Read here for more ...
Key Points Douglas Lane & Associates bought 16,745 shares of Thermo Fisher Scientific with an estimated trade value of around ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback